Drug Profile


Alternative Names: Diotul; F 3616; F 3616M; Flavalfate

Latest Information Update: 10 May 2007

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator FAES Farma
  • Class Antiulcers; Cytoprotectives; Flavones
  • Mechanism of Action
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Marketed NSAID-induced ulcer
  • Discontinued Duodenal ulcer; Gastric ulcer; Stress ulcer

Most Recent Events

  • 02 Aug 2000 A clinical study has been added to the Peptic Ulcers pharmacodynamics section
  • 02 Aug 2000 A study has been added to the pharmacokinetics and adverse events sections
  • 02 Aug 2000 Four studies have been added to the Peptic Ulcers therapeutic trials section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top